Table 4 Comparison of the demographic and clinical characteristics of the participants (with migraine and probable migraine) presenting with visual aura in < 51% and > 51% of all headache attacks.

From: Prevalence and impact of visual aura in migraine and probable migraine: a population study

 

Migraine with visual aura in ≥ 51% of all headache attacks, N = 13

Migraine with visual aura in < 51% of all headache attacks, N = 37

P value

PM with visual aura in ≥ 51% of all headache attacks, N = 15

PM with visual aura in < 51% of all headache attacks, N = 67

P value

Age (years)

38.0 (34.0–45.0)

41.0 (33.0–49.0)

0.595

37.0 (30.0–46.0)

45.0 (33.0–50.0)

0.117

Women

4 (30.8)

28 (75.7)

0.004

10 (66.7)

36 (53.7)

0.404

Frequency

2.0 (0.75–8.0)

4.0 (2.0–10.0)

0.719

4.0 (1.0–8.0)

2.0 (2.0–8.0)

0.555

HA days per month

2.0 (1.0–10.0)

5.0 (2.0–10.0)

0.282

3.0 (1.0–5.0)

2.0 (2.0–5.0)

0.336

Severe HA days per month

2.0 (1.0–5.0)

3.0 (1.0–5.5)

0.381

3.0 (1.0–5.0)

2.0 (1.0–3.0)

0.876

HA days with medication

1.0 (0.0–15.0)

3.0 (1.0–5.0)

0.518

2.0 (0.0–5.0)

2.0 (1.0–5.0)

0.615

Severe HA intensity

5 (38.5)

16 (43.2)

0.847

0 (0.0–0.0)

0 (0.0–0.0)

1.000

VAS score

7.0 (7.0–8.0)

7.0 (7.0–8.0)

0.655

7.0 (4.0–8.0)

6.0 (4.0–7.0)

0.455

HIT-6 score

50.0 (44.0–53.0)

54.0 (46.5–61.0)

0.545

46.0 (41.0–55.0)

50.0 (44.0–56.0)

0.328

MIDAS score

11.0 (6.0–41.5)

15.0 (9.0–15.0)

0.417

11.0 (5.0–47.0)

10.0 (5.0–24.0)

0.200

Unilateral pain

6 (46.2)

16 (43.2)

0.884

9 (60.0)

51 (76.1)

0.303

Pulsating pain

8 (61.5)

26 (70.3)

0.275

9 (60.0)

44 (65.7)

0.752

Aggravation by movement

11 (84.6)

29 (78.4)

0.215

12 (80.4)

44 (65.7)

0.268

Nausea

9 (69.2)

22 (59.5)

0.574

12 (80.0)

57 (85.1)

0.702

Vomiting

9 (69.2)

15 (40.4)

0.401

6 (40.0)

37 (55.2)

0.481

Photophobia

13 (100.0)

29 (78.4)

0.998

12 (80.0)

36 (53.7)

0.071

Phonophobia

9 (69.2)

22 (59.5)

0.121

11 (73.3)

42 (62.7)

0.567

WPI

3.0 (1.0–6.0)

6.0 (4.0–7.5)

0.559

7.0 (4.0–9.0)

4.0 (3.0–7.0)

0.028

PHQ-9 score

9.0 (7.5–10.5)

8.0 (6.0–9.0)

0.400

10.0 (8.0–18.0)

8.0 (6.0–9.0)

0.016

GAD-7 score

9.0 (4.5–10.5)

8.0 (3.0–13.0)

0.754

12.0 (5.0–15.0)

6.0 (4.0–9.0)

0.013

ASC-12 score

4.0 (2.5–8.0)

3.0 (0.5–8.0)

0.675

4.0 (2.0–8.0)

2.0 (0.0–6.0)

0.572

BEPSI-K score

3.0 (2.7–3.8)

2.6 (2.0–3.0)

0.045

3.2 (2.2–4.0)

2.2 (2.0–2.8)

0.006

M-TOQ-6 score

20.5 (15.3–22.8)

20.0 (16.5–24.3)

0.555

21.0 (18.0–26.0)

21.0 (17.0–25.0)

0.827

PSQI

9.0 (7.5–10.0)

7.0 (5.5–9.0)

0.130

10.0 (7.0–10.0)

7.0 (5.0–9.0)

0.032

  1. PM: probable migraine, HA: headache, VAS: visual analogue scale, HIT-6: Headache Impact Test-6, MIDAS: Migraine Disability Assessment, WPI: Widespread Pain Index, PHQ-9: Patient Health Questionnaire-9, GAD-7: Generalized Anxiety Disorder-7, ASC-12: 12-item Allodynia symptom checklist, BEPSI-K: Korean version Brief Encounter Psychosocial Instrument, M-TOQ-6: 6-item version of the Migraine-Treatment Optimization Questionnaire, PSQI: Pittsburgh Sleep Quality Index.